Form 8-K - Current report:
SEC Accession No. 0001447028-24-000006
Filing Date
2024-01-04
Accepted
2024-01-04 16:09:10
Documents
15
Period of Report
2023-12-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K abus-20231231.htm   iXBRL 8-K 35478
2 EX-10.1 ex101abus-wcollierseparati.htm EX-10.1 64118
3 EX-10.2 ex102abus-wcollierconsulti.htm EX-10.2 81119
4 EX-10.3 ex103fourthamendmenttommem.htm EX-10.3 17924
  Complete submission text file 0001447028-24-000006.txt   361565

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20231231.xsd EX-101.SCH 1898
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20231231_lab.xml EX-101.LAB 23834
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20231231_pre.xml EX-101.PRE 12506
9 EXTRACTED XBRL INSTANCE DOCUMENT abus-20231231_htm.xml XML 3027
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 24511902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)